The GMI Research report provides an overall outlook of the industry through a detailed market segmentation. The report offers thorough information related to the overview and scope of the market, including the market drivers, restraints and emerging trends in the industry. This report is especially designed to include both qualitative and quantitative aspects of the industry in each region and country participating in the study.
Competitive Rivalry of the Gene Editing Market:
The leading players in the gene editing market include Bio Rad, Sangamo Therapeutics, Intellia Therapeutics, DNA Technologies, CRISPR Therapeutics, Cellectis, Agilent Technologies, Allele Biotech, Thermo Fisher Scientific, and Editas Medicine, among others.
Drivers of the Gene Editing Market:
Increasing awareness about the engineering methods will boost the growth of the gene editing market. Moreover, continuous technology advancement is another key factor that is surging market growth. Growing treatments for cancer and genetic diseases are fuelling market growth. The rising focus on genetically modified organisms by the food industry and the increasing R&D investment by biotech and pharma companies are some other factors contributing to market growth. The gene editing technique is used to surge the yield of biological crops.
Increasing demand for synthetic genes in developed and developing countries will bolster market growth. In addition to this, the growing Chinese population faces food scarcity that improves the demand for GM crops and vegetables that will surge the demand for gene editing techniques used in producing bioengineered seeds. Furthermore, the rising preference for synthetic genes in manufacturing biologics and drugs used in cancer treatment will accelerate the market value. On the other hand, limited awareness associated with gene alteration therapies and increasing concerns for animal welfare and human welfare as a substitute for a gene for medical purposes will limit market growth. Government regulation is hindering the growth of this industry.
The main objective of the study is to define market sizes of the different market segments & countries during the forecast period and analyze the values in the next six years. The detailed segments and sub-segments of the market are explained below:
Breakup by Technology:
- Cluster Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Transcription Activator-Like Effector Nucleases (TALEN)
- Zing Finger Nucleases (ZFN)
Breakup by Application:
- Animal Genetic Engineering
o Therapeutic Application
o Genetically Modified Organisms
- Plant Genetic Engineering
- Cell Line Engineering
Breakup by End-User:
- Pharma-BioTech Companies
- Academic Institutes & Research Center
- Agrigenomic Companies
- Contract Research Organization
Breakup by Region:
- North America
o United States of America
- Asia Pacific
o Rest of APAC
o United Kingdom
o Rest of Europe
o South Africa
o Saudi Arabia
o Rest of the world (remaining countries of the LAMEA region)
About GMI Research
GMI Research is a market research and consulting firm which provides bespoke industry & market research to help businesses in making the toughest business decision. We know the significance of accurate data; that’s why our analyst use tailored methodology to study every market in detail because one size doesn’t fit all. We not only cover the traditional well-established market but also focuses on niche market and markets in the emerging economies, where getting data and information is a challenge. This factor makes us pioneer in emerging market research space. Our syndicate reports cover multiple industries across various regions and countries.
Our in-depth market reports help propel your business with all the data, strategic inputs, and competitive intelligence to move ahead even in the most uncertain times. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research look forward to help businesses stay ahead of the curve.
Company Name: GMI RESEARCH
Phone: +353 1 442 8820
Address: Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate